Judge In Sullivan Baby Doe Case Allows $2.4 Billion Judgment Trial Wednesday, April 7, 2021
In a ruling filed in Sullivan County Circuit Court on Tuesday, Chancellor E.G. Moody granted a default judgment against Endo Health Solutions, Inc. and Endo Pharmaceuticals, Inc. in the case of Staubus vs. Purdue, widely recognized as the Sullivan Baby Doe suit.
The judgment details a dozen false statements Endo’s attorneys made to the court, describes a “coordinated strategy between Endo and its counsel to…interfere with the administration of justice,” and holds the companies liable for damages sought, an amount that totals $2.4 billion, prosecutors said.
UPDATE:
BLOUNTVILLE â In a sweeping ruling in favor of a multi-county lawsuit against pharmaceutical companies that produce opioids, a judge granted a summary judgment against those companies, but delayed any decision on monetary damages.
In the ruling, filed in Sullivan County Circuit Court on Tuesday afternoon, Chancellor E.G. Moody granted a default judgment against Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. in the case of Staubus vs. Purdue, widely recognized as the Sullivan Baby Doe suit.
Moodyâs ruling did not assess damages in the case, but said that will be determined at a later date with a damages trial. The judgment details a dozen false statements Endoâs attorneys made to the court, describes a âcoordinated strategy between Endo and its counsel to ⦠interfere with the administration of justice,â and holds the companies liable for damages sought, an amount that totals $2.4 billion.
Endo Comments on Entry of Default Liability Judgment in Tennessee State Court Case prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Published: Feb 08, 2021
– Julie McHugh to become Executive Chair of the Board of Directors –
BOSTON (BUSINESS WIRE) Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that Mark Mallon plans to step down as chief executive officer and a member of the Ironwood Board of Directors in order to pursue another leadership opportunity, effective March 12, 2021. The Ironwood Board has named Thomas McCourt, Ironwood’s president, as interim CEO effective upon Mr. Mallon’s departure. Julie McHugh, Ironwood’s Board chair, will become executive chair of the Board of Directors effective upon Mr. Mallon’s departure and, in that capacity, will continue to lead the Board of Directors as well as provide counsel and guidance to the senior management team through the transition.
CHARLESTON – West Virginia will receive a $10 million settlement from a national consulting firm that allegedly designed marketing plans and programs that helped fuel the state s opioid epidemic.
Attorney General Patrick Morrisey announced the settlement February 4. His office says it resolves allegations that McKinsey & Company Inc. collected millions from the nation’s largest opioid manufacturers, most notably a more than 15-year relationship with Purdue Pharma, to boost sales of OxyContin even well after the opioid epidemic peaked.
“Marketing efforts to boost the profits of opioid drug makers have caused – and continue to cause – immense harm to West Virginia,” Morrisey said of West Virginia’s settlement. “Such strategies valued profits above human life, and those responsible must be held accountable.